<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03214055</url>
  </required_header>
  <id_info>
    <org_study_id>2017-0789</org_study_id>
    <nct_id>NCT03214055</nct_id>
  </id_info>
  <brief_title>Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy</brief_title>
  <official_title>Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy: a Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to evaluate the change in optic nerve sheath diameters as a surrogate of intracranial
      pressure before and after mannitol administration in patients who undergo robot assisted
      laparoscopic radical prostatectomy with pneumoperitoneum and Trendelenburg position.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mannitol has been frequently used for renal protection during surgery. Optic nerve sheath
      diameter is used to evaluate intracranial pressure noninvasively. Robot-assisted laparoscopic
      radical prostatectomy can induce an increase in optic nerve sheath diameter due to
      Trendelenburg position and carbon dioxide insufflation. We therefore aim to evaluate the
      change in optic nerve sheath diameters before and after mannitol administration in patients
      who undergo robot assisted laparoscopic radical prostatectomy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 12, 2017</start_date>
  <completion_date type="Actual">August 20, 2017</completion_date>
  <primary_completion_date type="Actual">August 14, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>7 Days</target_duration>
  <primary_outcome>
    <measure>Change in optic nerve sheath diameters</measure>
    <time_frame>5 minutes after pneumoperitoneum and Trendelenburg position, 90 minutes after mannitol administration during pneumoperitoneum and Trendelenburg position</time_frame>
    <description>Change in optic nerve sheath diameters before and after mannitol administration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in optic nerve sheath diameters</measure>
    <time_frame>5 minutes after pneumoperitoneum and Trendelenburg position, 60 minutes after mannitol administration during pneumoperitoneum and Trendelenburg position</time_frame>
    <description>Change in optic nerve sheath diameters before and after mannitol administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in optic nerve sheath diameters</measure>
    <time_frame>5 minutes after pneumoperitoneum and Trendelenburg position, 30 minutes after mannitol administration during pneumoperitoneum and Trendelenburg position</time_frame>
    <description>Change in optic nerve sheath diameters before and after mannitol administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optic nerve sheath diameter</measure>
    <time_frame>10 minutes after induction of anesthesia</time_frame>
    <description>Optic nerve sheath diameter before mannitol administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optic nerve sheath diameter</measure>
    <time_frame>Intraoperative (during skin closure)</time_frame>
    <description>Optic nerve sheath diameter after mannitol administration</description>
  </secondary_outcome>
  <enrollment type="Actual">39</enrollment>
  <condition>Prostate Cancer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mannitol</intervention_name>
    <description>The mannitol has been administered routinely to prevent renal dysfunction in patients undergoing robot-assisted laparoscopic radical prostatectomy. Participants will receive the mannitol as part of routine medical care, and we will evaluate the change in optic nerve sheath diameters before and after mannitol administration.</description>
    <other_name>Osmotic diuretic</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Prostate cancer patients who undergo Robot-assisted laparoscopic radical prostatectomy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  prostate cancer patients undergoing robot assisted laparoscopic radical prostatectomy.

          -  20 year old or above, 79 year old or below.

          -  agreed to participate this study.

        Exclusion Criteria:

          -  history of cerebrovascular accident.

          -  history of congestive heart failure.

          -  history of pulmonary edema.

          -  history of anaphylaxis to mannitol.

          -  conversion to open prostatectomy.

          -  combined with other operation.

          -  inability to measure optic nerve sheath diameter.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only male included.</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young-Kug Kim, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asan Medical center</name>
      <address>
        <city>Seoul</city>
        <zip>05555</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2017</study_first_submitted>
  <study_first_submitted_qc>July 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>August 24, 2017</last_update_submitted>
  <last_update_submitted_qc>August 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Young-Kug Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

